The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Neural basis of major depressive disorder: Beyond monoamine hypothesis
Open accessAbstract
The monoamine hypothesis has been accepted as the most common hypothesis of major depressive disorder (MDD) for a long period because of its simplicity and understandability. Actually, most currently used antidepressants have been considered to act based on the monoamine hypothesis. However, an important problem of the monoamine hypothesis has been pointed out as follows: it fails to explain the latency of response to antidepressants. In addition, many patients with MDD have remained refractory to currently used antidepressants. Therefore, monoamine-alternate hypotheses are required to explain the latency of response to antidepressants. Such hypotheses have been expected to contribute to identifying hopeful new therapeutic targets for MDD. Past studies have revealed that the volume of the hippocampus is decreased in patients with MDD, which is likely caused by the failure of the hypothalamic-pituitary-adrenal axis and following elevation of glucocorticoids. Two hypotheses have been proposed to explain the volume of the hippocampus: (i) the neuroplasticity hypothesis; and (ii) the neurogenesis hypothesis. The neuroplasticity hypothesis explains how the hippocampal volume is decreased by the morphological changes of hippocampal neurons, such as the shortening length of dendrites and the decreased number and density of spines. The neurogenesis hypothesis explains how the hippocampal volume is decreased by the decrease of neurogenesis in the hippocampal dentate gyrus. These hypotheses are able to explain the latency of response to antidepressants. In this review, we first overview how the neuroplasticity and neurogenesis hypotheses have been developed. We then describe the details of these hypotheses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a complex relationship between the HPA axis, glucocorticoid receptors, epigenetic mechanisms, and psychiatric sequelae [130,212].”
From Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature (2021) · cites this paper as [212]
In the citing paper
“The results show that factors, such as low cognitive ability/function, cognitive vulnerability, cognitive impairment or deficits, subjective cognitive decline, regression of dendritic branching and hippocampal atrophy/death of hippocampal cells, impaired neuroplasticity, and neurogenesis-related aspects, have been linked to depression [131,212,222,223,224,225,226,227,228,229,230,231,232,233,234,2”
From Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature (2021) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592
Kuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Cited by
Sorted by citations
Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature
Remes, O., Mendes, J. F., & Templeton, P. (2021) · Brain Sciences · doi:10.3390/brainsci11121633 · Cited by 482
van Velzen, L. S., Kelly, S., Isaev, D., Aleman, A., Aftanas, L. I., Bauer, J., Baune, B. T., Brak, I. V., Carballedo, A., Connolly, C. G., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0477-2 · Cited by 369
Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 367
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Roohi, E., Jaafari, N., & Hashemian, F. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02100-7 · Cited by 256
Chudzik, A., Orzyłowska, A., Rola, R., & Stanisz, G. J. (2021) · Biomolecules · doi:10.3390/biom11071000 · Cited by 222
Losing DNA methylation at repetitive elements and breaking bad
Pappalardo, X. G., & Barra, V. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00400-z · Cited by 165
Neuroinflammation and cognition across psychiatric conditions
Fourrier, C., Singhal, G., & Baune, B. T. (2019) · CNS Spectrums · doi:10.1017/s1092852918001499 · Cited by 162
Eicher, T. P., & Mohajeri, M. H. (2022) · Nutrients · doi:10.3390/nu14132661 · Cited by 150
Suda, K., & Matsuda, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031172 · Cited by 154
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 159
Yang, Z., Li, J., Gui, X., Shi, X., Bao, Z., Han, H., & Li, M. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0729-1 · Cited by 139
BDNF Impact on Biological Markers of Depression—Role of Physical Exercise and Training
Murawska‐Ciałowicz, E., Wiatr, M., Ciałowicz, M., de Assis, G. G., Borowicz, W., Rocha‐Rodrigues, S., Paprocka‐Borowicz, M., & Marques, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147553 · Cited by 149
Bhatt, S., Devadoss, T., Manjula, S. N., & Rajangam, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666201015155816 · Cited by 119
Zhu, F., Tu, H., & Chen, T. (2022) · Nutrients · doi:10.3390/nu14102081 · Cited by 123
Hu, B., Das, P., Lv, X., Shi, M., Aa, J., Wang, K., Duan, L., Gilbert, J. A., Nie, Y., & Wu, X. (2022) · mSystems · doi:10.1128/msystems.00218-22 · Cited by 112
Behavioral and structural adaptations to stress
Cameron, H. A., & Schoenfeld, T. J. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.002 · Cited by 110
Guan, W., Xu, D., Ji, C.-H., Wang, C., Liu, Y., Tang, W., Gu, J., Chen, Y., Huang, J., Liu, J., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105932 · Cited by 103
Neurogenesis and antidepressant action
Park, S. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03043-5 · Cited by 101
Gunnewiek, T. M. K., van Hugte, E., Frega, M., Guardia, G. S., Foreman, K., Panneman, D. M., Mossink, B., Linda, K., Keller, J. M., Schubert, D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107538 · Cited by 90
Tao, W., Ruan, J., Wu, R., Zhao, M., Zhao, T. T., Qi, M., Yau, S., Yao, G., Zhang, H., Hu, Y., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.02.015 · Cited by 85
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Role of Brain-Gut-Microbiota Axis in Depression: Emerging Therapeutic Avenues
Bhatt, S., Kanoujia, J., Lakshmi, S. M., Patil, C., Gupta, G., Chellappan, D. K., & Dua, K. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220329140804 · Cited by 81
Shen, C., Tang, Y., Gao, Y., Nie, K., Wang, H., Su, H., Wang, Z., Lu, F., Huang, W., & Dong, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865376 · Cited by 83
Targeting inflammation: a potential approach for the treatment of depression
Bhatt, S., Devadoss, T., Jha, N. K., Baidya, M., Gupta, G., Chellappan, D. K., Singh, S. K., & Dua, K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01095-1 · Cited by 83
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Fu, X., Wang, Y., Zhao, F., Cui, R., Xie, W., Liu, Q., & Yang, W. (2023) · Aging · doi:10.18632/aging.204847 · Cited by 87
Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes
Xu, W., Yao, X., Zhao, F., Zhao, H., Cheng, Z., Yang, W., Cui, R., Xu, S., & Li, B. (2020) · Neural Plasticity · doi:10.1155/2020/8861903 · Cited by 75
Leschik, J., Lutz, B., & Gentile, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147339 · Cited by 77
Wu, J., Li, J., Chhetri, G., Muhammad, U., Chen, Y., Li, X., Chen, J., & Wang, Z. (2021) · General Psychiatry · doi:10.1136/gpsych-2021-100529 · Cited by 70
Bifidobacterium: a probiotic for the prevention and treatment of depression
Li, J., Wang, J., Wang, M., Zheng, L., Cen, Q., Wang, F., Li, Z., Pang, R., & Zhang, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174800 · Cited by 75
Chen, C., & Nakagawa, S. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/171565 · Cited by 77
Lee, M. T., Peng, W., Kan, H., Wu, C., Wang, D., & Ho, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10051005 · Cited by 67
Li, S., Yang, D., Zhou, C., Chen, L., Liu, L., Lin, R., Li, X., Liu, Y., Qiu, H., Cao, H., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14497 · Cited by 75
Transient and sustained effects of dopamine and serotonin signaling in motivation‐related behavior
Yagishita, S. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12942 · Cited by 68
Chang, J., Jiang, T., Shan, X., Zhang, M., Li, Y. Y., Qi, X., Bian, Y., & Zhao, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110931 · Cited by 72
Flux, M. C., & Lowry, C. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104578 · Cited by 70
Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?
de Miranda, A. S., de Barros, J. L. V. M., & Teixeira, A. L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1846720 · Cited by 67
Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice
Yu, X., Zhang, H., Dai, Y., Zhou, Z., Xu, R.-A., Hu, L., Zhang, C., Xu, H., An, Y., Tang, C., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.086 · Cited by 62
Li, H., Xiao, Y., Han, L., Jia, Y., Luo, S., Zhang, D., Zhang, L., Wu, P., Xiao, C., Kan, W., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.03.002 · Cited by 62
Dopaminergic system and neurons: Role in multiple neurological diseases
Chen, H., Li, J., Huang, Z., Fan, X., Wang, X., Chen, X., Guo, H., Liu, H., Li, S., Yu, S., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110133 · Cited by 69
Integrin adhesion in brain assembly: From molecular structure to neuropsychiatric disorders
Jaudon, F., Thalhammer, A., & Cingolani, L. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14859 · Cited by 59
Temporomandibular disorders and mental health: shared etiologies and treatment approaches
Wan, J., Lin, J., Zha, T., Ciruela, F., Jiang, S., Wu, Z., Fang, X., Chen, Q., & Chen, X. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01985-6 · Cited by 77
MicroRNAs as critical biomarkers of major depressive disorder: a comprehensive perspective
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Lahera, G., Monserrat, J., Muñoz-Merida, L., Mora, F., Rodríguez-Jiménez, R., Fernandez-Rojo, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111659 · Cited by 57
Ishimoto, T., & Kato, Y. (2022) · FEBS Letters · doi:10.1002/1873-3468.14271 · Cited by 59
Zhong, H., Xiao, R., Ruan, R., Liu, H., Li, X., Cai, Y., Zhao, J., & Fan, X. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05634-5 · Cited by 53
Mechanisms of Cognitive Impairment in Depression. May Probiotics Help?
Dobielska, M., Bartosik, N. K., Zyzik, K. A., Kowalczyk, E., & Karbownik, M. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.904426 · Cited by 57
Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Jembrek, M. J., Oršolić, N., Karlović, D., & Peitl, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086888 · Cited by 58
Yosaee, S., Clark, C. C. T., Keshtkaran, Z., Ashourpour, M., Keshani, P., & Soltani, S. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.08.001 · Cited by 48
Muntsant-Soria, A., & Giménez‐Llort, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.572583 · Cited by 53
Chen, W.-G., Zheng, J., Xu, X., Hu, Y., & Ma, Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.025 · Cited by 47
Eye Movement Abnormalities in Major Depressive Disorder
Takahashi, J., Hirano, Y., Miura, K., Morita, K., Fujimoto, M., Yamamori, H., Yasuda, Y., Kudo, N., Shishido, E., Okazaki, K., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.673443 · Cited by 45
Chakrapani, S., Eskander, N., Santos, L. A. D. L., Omisore, B. A., & Mostafa, J. A. (2020) · Cureus · doi:10.7759/cureus.11396 · Cited by 48
Wang, Y., Liu, L., Gu, J., Wang, C., Guan, W., Liu, Y., Tang, W., Ji, C.-H., Chen, Y., Huang, J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01881-4 · Cited by 44
Han, H., Yao, J., Wu, J., Mao, S., Pan, H., Qv, L., Zhu, G., Ren, J., Yu, Y., Xuan, F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03044-7 · Cited by 46
Astrocytes in depression and Alzheimer’s disease
Liao, Y., Xing, Q., Li, Q., Zhang, J., Pan, R., & Yuan, Z. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0875-0 · Cited by 44
Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Tomasetti, C., Montemitro, C., Fiengo, A. L. C., Santone, C., Orsolini, L., Valchera, A., Carano, A., Pompili, M., Serafini, G., Perna, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190312102444 · Cited by 44
Mitochondria could be a potential key mediator linking the intestinal microbiota to depression
Chen, J., & Vitetta, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29311 · Cited by 36
Zhang, K., He, M.-Y., Wang, F., Zhang, H., Li, Y., Yang, J., & Wu, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00834 · Cited by 39
The preclinical discovery and development of agomelatine for the treatment of depression
Konstantakopoulos, G., Dimitrakopoulos, S., & Michalopoulou, P. G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1781087 · Cited by 40
Fronza, M. G., Baldinotti, R., Fetter, J., Rosa, S. G., Sacramento, M., Nogueira, C. W., Alves, D. A. C., Praticò, D., & Savegnago, L. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.002 · Cited by 38
Dietary Patterns and Intrinsic Capacity in Community-Dwelling Older Adults: A Cross-Sectional Study
Yeung, S. S. Y., Sin, D., Yu, R., Leung, J. C. S., & Woo, J. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1742-7 · Cited by 36
The antidepressant-like effect of formononetin on chronic corticosterone-treated mice
Zhang, C., Zhu, L., Lu, S., Li, M., Bai, M., Li, Y., & Xu, E. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147844 · Cited by 38
Repurposing of Drugs–The Ketamine Story
Das, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01193 · Cited by 41
Stolicyn, A., Lyall, L. M., Lyall, D. M., Høier, N. K., Adams, M. J., Shen, X., Cole, J. H., McIntosh, A. M., Whalley, H. C., & Smıth, D. J. (2023) · SLEEP · doi:10.1093/sleep/zsad274 · Cited by 36
Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
Shao, Q., Wu, Y., Ji, J., Xu, T., Yu, Q., Ma, C., Liao, X., Cheng, F., & Wang, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.711835 · Cited by 32
GHS-R1a Deficiency Alleviates Depression-Related Behaviors After Chronic Social Defeat Stress
Guo, L., Niu, M., Yang, J., Li, L., Liu, S., Sun, Y., Zhou, Z., & Zhou, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00364 · Cited by 34
Xing, H., Zhang, X., Xing, N., Qu, H., & Zhang, K. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112079 · Cited by 33
Jiang, T., Hu, S., Dai, S., Yi, Y., Wang, T., Li, X., Luo, M., Li, K., Chen, L., Wang, H., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09590-4 · Cited by 33
Cordner, Z. A., Marshall-Thomas, I., Boersma, G. J., Lee, R. S., Potash, J. B., & Tamashiro, K. L. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100392 · Cited by 33
Brain‐wide cellular mapping of acute stress‐induced activation in male and female mice
Kim, W., & Chung, C. (2021) · The FASEB Journal · doi:10.1096/fj.202101287r · Cited by 33
Paolini, M., Harrington, Y. A., Colombo, F., Bettonagli, V., Poletti, S., Carminati, M., Colombo, C., Benedetti, F., & Zanardi, R. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231190859 · Cited by 33
MicroRNAs in Major Depressive Disorder
Fries, G. R., Zhang, W., Benevenuto, D., & Quevedo, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_9 · Cited by 29
Liu, X., Li, X., Teng, T., Jiang, Y., Xiang, Y., Fan, L., Yu, Y., Zhou, X., & Xie, P. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.088 · Cited by 33
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
D, M. F. M., Stahl, S. M., Martin, S. D., Mattarei, A., Bettini, E., Comai, S., Alimonti, A., Bifari, F., Pani, L., Folli, F. B., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01571-4 · Cited by 32
Truong, V., Cheng, P. Z., Lee, H., Lane, T. J., Hsu, T., & Duncan, N. W. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111238 · Cited by 31
Yeung, S. S.-H., Ho, J. Y. S., & Chang, R. C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00660-5 · Cited by 32
Depression-associated gut microbes, metabolites and clinical trials
Wang, M., Song, Z., Lai, S., Tang, F., Dou, L., & Yang, F. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1292004 · Cited by 32
Acupuncture may play a key role in anti-depression through various mechanisms in depression
Li, P., Zhao, J., Wei, X., Luo, L., Chu, Y., Zhang, T., Zhu, A., & Yan, J. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00990-2 · Cited by 32
Stress, memory, and implications for major depression
de Sousa, G. M., Vargas, H. D. Q., Barbosa, F. F., & Coelho, N. L. G. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113410 · Cited by 32
Hai-Na, Z., Xu-Ben, Y., Cong-Rong, T., Yan-Cheng, C., Fan, Y., Lei-Mei, X., Ruo-Lan, S., Ye-Zi, Ye-Xuan, W., & Jing, L. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05406-w · Cited by 29
Nutritional therapy can reduce the burden of depression management in low income countries: A review
Ekong, M. B., & Iniodu, C. F. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.06.002 · Cited by 28
Wu, J., Wang, L., Cui, Y., Liu, F., & Zhang, J. (2023) · Molecules · doi:10.3390/molecules28062485 · Cited by 28
Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder
He, X.-L., Yang, L., Wang, Z., Huang, R., Zhu, R., & Cheng, L.-M. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293155 · Cited by 28
The safety and efficacy of botulinum toxin A on the treatment of depression
Zhang, Q., Wu, W., Fan, Y., Li, Y., Liu, J., Xu, Y., Jiang, C., Tang, Z., Cao, C., Liu, T., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2333 · Cited by 27
Bupleurum in Treatment of Depression Disorder: A Comprehensive Review
Ran, S., Peng, R., Guo, Q., Cui, J., Chen, G., & Wang, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17040512 · Cited by 26
Tanichi, M., Toda, H., Shimizu, K., Koga, M., Saito, T., Enomoto, S., Boku, S., Asai, F., Mitsui, Y., Nagamine, M., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.023 · Cited by 26
The roles of extracellular vesicles in major depressive disorder
Li, Y., Gui, Y., Zhao, M., Chen, X., Li, H., Chen, T., Zhao, H., Jiang, C., Xu, P., Zhang, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1138110 · Cited by 27
Frontal Alpha Asymmetry and Its Modulation by Monoaminergic Neurotransmitters in Depression
Fitzgerald, P. J. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1138 · Cited by 26
New insights into anti-depression effects of bioactive phytochemicals
Zhao, R., Wang, J., Chung, S. K., & Xu, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107566 · Cited by 29
de Almeida, G. R. L., Szczepanik, J. C., Selhorst, I., Schmitz, A. E., dos Santos, B., Cunha, M. P., Heinrich, I. A., de Paula, G. C., Bem, A. F. D., Leal, R. B., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02146-3 · Cited by 25
Papakostas, G. I., Johe, K. K., Hand, H., Drouillard, A., Russo, P. A., Kay, G. G., Kashambwa, R., Hoeppner, B. B., Flynn, M., Yeung, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0334-8 · Cited by 25
Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles
Stenovec, M., Božić, M., Pirnat, S., & Zorec, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02744-1 · Cited by 25
Zhao, L., Wang, D., Xue, S., Tan, Z., Wang, Y., & Lian, Z. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.003 · Cited by 24
Stahl, S. M., Martin, S. D., Mattarei, A., Bettini, E., Pani, L., Guidetti, C., Folli, F. B., de Somer, M., Traversa, S., Inturrisi, C. E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012196 · Cited by 24
The antidepressant-like effects of Danzhi Xiaoyao San and its active ingredients
Xie, Z., Xie, H., Peng, X., Hu, J., Chen, L., Li, X., Hu, Q., Zeng, J., & Zeng, N. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155015 · Cited by 23
Is There an Association Between Migraine and Major Depressive Disorder? A Narrative Review
Jahangir, S., Adjepong, D., Al-Shami, H., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.8551 · Cited by 23
Sun, J., Liu, Y., Jiang, S.-N., Guo, P.-M., Wu, X.-Y., & Yu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.999712 · Cited by 23
Li, K., Wang, K., Xu, S., Xie, X., Tang, Y., Zhang, L., & Liu, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s477482 · Cited by 23
The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy
Bernstein, H., Dobrowolny, H., Bogerts, B., Keilhoff, G., & Steiner, J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2849-3 · Cited by 26
Koshiyama, D., Kirihara, K., Usui, K., Tada, M., Fujioka, M., Morita, S., Kawakami, S., Yamagishi, M., Sakurada, H., Sakakibara, E., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.030 · Cited by 22
Setoyama, D., Yoshino, A., Takamura, M., Okada, G., Iwata, M., Tsunetomi, K., Ohgidani, M., Kuwano, N., Yoshimoto, J., Okamoto, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.118 · Cited by 23
Metadata
- Authors
- Boku, S., Nakagawa, S., Toda, H., & Hishimoto, A.
- Affiliations
- Kobe University (JP)
- Hokkaido University (JP)
- National Defense Medical College Hospital (JP)
- Corresponding author
- Boku, Shuken
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2017-10-19
- Volume
- 72
- Issue
- 1
- Pages
- 3-12
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W2770859047
- Cited by
- 402
- References
- 79
- Citations by year
- 2026: 30 · 2025: 52 · 2024: 61 · 2023: 58 · 2022: 56 · 2021: 72 · 2020: 38 · 2019: 26 · 2018: 9
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psychiatry and Clinical Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- major depressive disorder, monoamine hypothesis, antidepressant resistance, hippocampal volume, hippocampal neurogenesis, dentate gyrus, hypothalamic-pituitary-adrenal axis, glucocorticoids, therapeutic target
- MeSH terms
- Major Depressive Disorder, Glucocorticoids, Hippocampus, Humans, Hypothalamo-Hypophyseal System, Neuronal Plasticity, Pituitary-Adrenal System, Stress, Psychological, Neurotransmitter Agents, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review